Results 31 to 40 of about 568,124 (227)
Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology
Many traditional vaccines have proven to be incapable of controlling newly emerging infectious diseases. They have also achieved limited success in the fight against a variety of human cancers.
M. Bello +6 more
semanticscholar +1 more source
Newcastle Disease merupakan penyakit unggas yang sangat menular dan sangat mematikan pada semua unggas. Penelitian ini bertujuan mengetahui lesi dan distribusi virus Newcastle disease pada organ limpa dan bursa Fabricious ayam dari kasus-kasus lapangan ...
Etriwati Etriwati +2 more
doaj +1 more source
Investigations of hemadsorption characteristics of glycoprotein HN and F antigens of Newcastle Disease virus envelope in vitro [PDF]
The objective of these investigations was to examine the hemadsorption characteristics of glycoprotein HN and F antigens of the Newcastle Disease virus envelope.
Nišavić Jakov, Milić Nenad
doaj +1 more source
Precursor Protein for Newcastle Disease Virus [PDF]
The course of viral protein synthesis during infection of chicken embryo fibroblasts with Newcastle disease virus (NDV) L. Kansas has been followed by using sodium dodecyl sulfate polyacrylamide gel electrophoresis. Of the three major virion polypeptide molecular weight classes, I (78,400 daltons), II (53,500 daltons), and III (37,600 daltons), only II,
A C, Samson, C F, Fox
openaire +2 more sources
Newcastle disease virus (NDV) causes severe infectious disease in poultry and selectively kills tumor cells, by inducing apoptosis and cytokines secretion.
Yanrong Li +9 more
semanticscholar +1 more source
Characterization of hemagglutination activity of emerging Newcastle disease virus in Bangladesh [PDF]
Aim: Newcastle disease (ND) is an important viral disease for poultry caused by avian paramyxovirus which can be identified by its nature of agglutination activity with red blood cell (RBC) of different species.
Helal Uddin +4 more
doaj +1 more source
Resistance to therapy is a major obstacle to cancer treatment. It may exist from the beginning, or it may develop during therapy. The review focusses on oncolytic Newcastle disease virus (NDV) as a biological agent with potential to break therapy ...
V. Schirrmacher +2 more
semanticscholar +1 more source
After publication of the article [1], it has been brought to our attention that Newcastle disease virus was incorrectly labeled as a Tier 1 USDA Select Agent. Newcastle disease virus is a USDA Select Agent but it is not a Tier 1 agent.
Vienna R. Brown, Sarah N. Bevins
doaj +1 more source
Transcriptional map for Newcastle disease virus [PDF]
A transcriptional map of Newcastle disease virus was determined by measuring the kinetics of UV inactivation of the transcription of individual genes and of viral infectivity. The inactivation of single genes was monitored by measuring the reduction in the accumulation of viral gene products in vivo and in vitro.
P L, Collins, L E, Hightower, L A, Ball
openaire +2 more sources
Background Oncolytic viro-immunotherapy holds promise for cancer treatment. While immune activation can be robustly triggered by oncolytic viruses, negative feedback is often upregulated in the tumour microenvironment (TME).
Gang Meng +9 more
semanticscholar +1 more source

